Martingale Asset Management L P Adaptive Biotechnologies Corp Transaction History
Martingale Asset Management L P
- $3.87 Billion
- Q1 2025
A detailed history of Martingale Asset Management L P transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Martingale Asset Management L P holds 58,325 shares of ADPT stock, worth $575,667. This represents 0.01% of its overall portfolio holdings.
Number of Shares
58,325
Previous 58,621
0.5%
Holding current value
$575,667
Previous $351,000
23.36%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$296 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$129 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$115 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$110 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$76.3 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.41B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...